首页 > 最新文献

Clinical medicine. Cardiology最新文献

英文 中文
Acute coronary syndrome in pregnancy. 妊娠期急性冠脉综合征。
Pub Date : 2009-12-08 DOI: 10.4137/cmc.s3284
Douglas Wright, Claire Kenny-Scherber, Alison Montgomery, Omid Salehian

Acute coronary syndrome (ACS) in pregnancy has traditionally been considered to be a rare event, but the combination of normal physiological changes of pregnancy and more prevalent cardiovascular risk factors are increasing its incidence in this population. The present report describes a 39 year-old woman that is seven weeks pregnant presenting with a non ST elevation myocardial infarction. The incidence, risk factors, pathophysiology and management of ACS in pregnancy are discussed.

妊娠期急性冠脉综合征(ACS)历来被认为是一种罕见的事件,但妊娠期正常的生理变化和更普遍的心血管危险因素的结合正在增加其在这一人群中的发病率。本报告描述了一个39岁的妇女,怀孕7周,表现为非ST段抬高心肌梗死。本文就妊娠期ACS的发生率、危险因素、病理生理及处理进行了讨论。
{"title":"Acute coronary syndrome in pregnancy.","authors":"Douglas Wright,&nbsp;Claire Kenny-Scherber,&nbsp;Alison Montgomery,&nbsp;Omid Salehian","doi":"10.4137/cmc.s3284","DOIUrl":"https://doi.org/10.4137/cmc.s3284","url":null,"abstract":"<p><p>Acute coronary syndrome (ACS) in pregnancy has traditionally been considered to be a rare event, but the combination of normal physiological changes of pregnancy and more prevalent cardiovascular risk factors are increasing its incidence in this population. The present report describes a 39 year-old woman that is seven weeks pregnant presenting with a non ST elevation myocardial infarction. The incidence, risk factors, pathophysiology and management of ACS in pregnancy are discussed.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"125-31"},"PeriodicalIF":0.0,"publicationDate":"2009-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s3284","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29022033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Osler-Weber-Rendu (OWR) Disease and Heart Failure. 奥斯勒-韦伯-伦杜(OWR)病和心力衰竭。
Pub Date : 2009-11-25 DOI: 10.4137/cmc.s3636
Arnon Blum, Rafea Shalabi

OWR is a genetic disease, transmitted as an autosomal dominant disorder characterized by arteriovenous malformations predominantly involving the mucocutaneous epithelium. One of the significant complications is the development of arteriovenous fistulas in different organs like the liver and brain. One of the rarest complications of this arteriovenous conduit is a high-output heart failure. We would like to describe a 66 years old woman who was admitted with a high-output cardiac failure who deteriorated clinically and was treated successfully by conservative management.

动静脉畸形是一种遗传病,是一种常染色体显性遗传疾病,其特征是动静脉畸形主要累及粘膜上皮。主要并发症之一是在肝脏和大脑等不同器官中形成动静脉瘘。这种动静脉导管最罕见的并发症之一是高输出性心力衰竭。我们要描述的是一名因高输出量心力衰竭入院的 66 岁女性,她的临床病情恶化,经保守治疗后获得成功。
{"title":"Osler-Weber-Rendu (OWR) Disease and Heart Failure.","authors":"Arnon Blum, Rafea Shalabi","doi":"10.4137/cmc.s3636","DOIUrl":"10.4137/cmc.s3636","url":null,"abstract":"<p><p>OWR is a genetic disease, transmitted as an autosomal dominant disorder characterized by arteriovenous malformations predominantly involving the mucocutaneous epithelium. One of the significant complications is the development of arteriovenous fistulas in different organs like the liver and brain. One of the rarest complications of this arteriovenous conduit is a high-output heart failure. We would like to describe a 66 years old woman who was admitted with a high-output cardiac failure who deteriorated clinically and was treated successfully by conservative management.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"121-3"},"PeriodicalIF":0.0,"publicationDate":"2009-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29022032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of nebivolol on endothelial function and exercise parameters in patients with slow coronary flow. 奈比洛尔对冠脉血流缓慢患者内皮功能和运动参数的影响。
Pub Date : 2009-11-03 DOI: 10.4137/cmc.s3725
Selma Tiryakioglu, Osman Tiryakioglu, Hasan Ari, Mehmet C Basel, Tahsin Bozat

Objective: Earlier studies have reported that a decrease in exercise capacity might indicate endothelial dysfunction. However, the effects of improvement of endothelial functions on exercise capacity have not been evaluated. The aim of the present study is to investigate the effects of nebivolol on flow-mediated dilatation (FMD), and on the exercise capacities of the patients with slow coronary flow (SCF).

Methods: The study population included 25 subjects with SCF (Group 1) documented by the thrombolysis in myocardial infarction (TIMI) frame count, and 25 control group (Group 2) subjects with normal coronary angiography, for a total of 50 subjects who underwent coronary angiography due to several indications and had no coronary lesion. The TIMI frame count (TFC) values of the subjects in Group I for left anterior descending artery, right coronary, and circumflex coronary artery were 61.8 +/- 30.6, 37.2 +/- 17.4, and 34.6 +/- 17.4, respectively. All the subjects received nebivolol 5 mg/day.

Results: At the end of the first month of FMD, the mean exercise duration (MED) and the Duke Scores of the patients with SCF were significantly higher than the baseline values. However, the values by the sixth month did not differ from that at the first month. Although a numerical improvement compared to the baseline values was observed for the subjects in Group 2 by the measurements at the end of the first and the sixth month, this difference was not statistically significant.

Conclusions: Nebivolol treatment increases FMD in the subjects with SCF. The difference in the exercise parameters of these subjects is particularly dramatic, and such an outcome may indirectly indicate long-term improvement in endothelial function.

目的:早期的研究报道了运动能力的下降可能表明内皮功能障碍。然而,内皮功能改善对运动能力的影响尚未得到评估。本研究的目的是探讨奈比洛尔对血流介导扩张(FMD)和慢冠状动脉血流(SCF)患者运动能力的影响。方法:研究人群包括25例经心肌梗死溶栓(TIMI)帧计数记录的SCF患者(第一组)和25例冠状动脉造影正常的对照组(第二组),共50例因多种适应症行冠状动脉造影且无冠状动脉病变的患者。第一组受试者左前降支、右冠状动脉和旋冠状动脉的TIMI框架计数(TFC)分别为61.8 +/- 30.6、37.2 +/- 17.4和34.6 +/- 17.4。所有受试者均给予奈比洛尔5mg /d。结果:在FMD的第一个月结束时,SCF患者的平均运动持续时间(MED)和Duke评分显著高于基线值。然而,第六个月的数值与第一个月的数值没有差异。虽然在第一个月和第六个月末的测量中观察到第二组受试者的数值比基线值有所改善,但这种差异没有统计学意义。结论:奈比洛尔治疗可增加SCF患者的FMD。这些受试者的运动参数差异尤其显著,这样的结果可能间接表明内皮功能的长期改善。
{"title":"Effects of nebivolol on endothelial function and exercise parameters in patients with slow coronary flow.","authors":"Selma Tiryakioglu,&nbsp;Osman Tiryakioglu,&nbsp;Hasan Ari,&nbsp;Mehmet C Basel,&nbsp;Tahsin Bozat","doi":"10.4137/cmc.s3725","DOIUrl":"https://doi.org/10.4137/cmc.s3725","url":null,"abstract":"<p><strong>Objective: </strong>Earlier studies have reported that a decrease in exercise capacity might indicate endothelial dysfunction. However, the effects of improvement of endothelial functions on exercise capacity have not been evaluated. The aim of the present study is to investigate the effects of nebivolol on flow-mediated dilatation (FMD), and on the exercise capacities of the patients with slow coronary flow (SCF).</p><p><strong>Methods: </strong>The study population included 25 subjects with SCF (Group 1) documented by the thrombolysis in myocardial infarction (TIMI) frame count, and 25 control group (Group 2) subjects with normal coronary angiography, for a total of 50 subjects who underwent coronary angiography due to several indications and had no coronary lesion. The TIMI frame count (TFC) values of the subjects in Group I for left anterior descending artery, right coronary, and circumflex coronary artery were 61.8 +/- 30.6, 37.2 +/- 17.4, and 34.6 +/- 17.4, respectively. All the subjects received nebivolol 5 mg/day.</p><p><strong>Results: </strong>At the end of the first month of FMD, the mean exercise duration (MED) and the Duke Scores of the patients with SCF were significantly higher than the baseline values. However, the values by the sixth month did not differ from that at the first month. Although a numerical improvement compared to the baseline values was observed for the subjects in Group 2 by the measurements at the end of the first and the sixth month, this difference was not statistically significant.</p><p><strong>Conclusions: </strong>Nebivolol treatment increases FMD in the subjects with SCF. The difference in the exercise parameters of these subjects is particularly dramatic, and such an outcome may indirectly indicate long-term improvement in endothelial function.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"115-9"},"PeriodicalIF":0.0,"publicationDate":"2009-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s3725","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29022031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Left ventricular rupture post mitral valve replacement. 二尖瓣置换术后左心室破裂。
Pub Date : 2009-09-23 DOI: 10.4137/cmc.s2533
Sameh I Sersar, Ahmed A Jamjoom

Prevention is better than cure best applies here. As per many authors, posterior leaflet chordae preservation prevent Left ventricular rupture (LVR) and preserve LV geometry. We are presenting here 5 types of left ventricular rupture (LVR) post Mitral valve replacement (MVR) with different methods to repair with the advantages and disadvantages of each. The mortality rate is still very high despite the advances in cardiac surgery. Many therapeutic approaches have been adopted. Yet, none is ideal.

预防胜于治疗在这里最适用。许多学者认为,保留后叶绒毛可预防左心室破裂(LVR)并保留左心室的几何形状。我们在此介绍二尖瓣置换术(MVR)后左室破裂(LVR)的五种类型,以及不同的修复方法和各自的优缺点。尽管心脏外科技术不断进步,但死亡率仍然很高。目前已采用了许多治疗方法。然而,没有一种是理想的。
{"title":"Left ventricular rupture post mitral valve replacement.","authors":"Sameh I Sersar, Ahmed A Jamjoom","doi":"10.4137/cmc.s2533","DOIUrl":"10.4137/cmc.s2533","url":null,"abstract":"<p><p>Prevention is better than cure best applies here. As per many authors, posterior leaflet chordae preservation prevent Left ventricular rupture (LVR) and preserve LV geometry. We are presenting here 5 types of left ventricular rupture (LVR) post Mitral valve replacement (MVR) with different methods to repair with the advantages and disadvantages of each. The mortality rate is still very high despite the advances in cardiac surgery. Many therapeutic approaches have been adopted. Yet, none is ideal.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"101-13"},"PeriodicalIF":0.0,"publicationDate":"2009-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29022030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stress cardiomyopathy (takotsubo cardiomyopathy). 应激性心肌病(takotsubo心肌病)。
Pub Date : 2009-09-17 DOI: 10.4137/cmc.s3324
Samer Khouri, Naser Imran

Background: Due to the rise in the number of reports of stress cardiomyopathy in the literature, awareness of this condition is increasing. Although different names have been used to describe this condition, the similarities in clinical, electrocardiographic, echocardiographic, and angiographic features suggest that they represent the same spectrum of diseases with different underlying causes. The pathophysiology of stress cardiomyopathy remains controversial.

Methods: We describe a series of four cases of stress cardiomyopathy admitted to our institution over a period of six months with different presentations, but similar clinical course, EKG, echocardiographic, and catheterization findings. The ages ranged from 22 to 81 years; all four females. All showed characteristic wall motion abnormalities by imaging in the absence of significant coronary artery disease, with spontaneous recovery of left ventricular function with conservative therapy.

Results: Although the patients presented with different clinical scenarios, all four showed characteristic features of stress cardiomyopathy suggesting that the pathophysiology affecting the myocardium was the same. We present a review of the literature with a discussion of the history of this condition, characteristic clinical features, and diagnostic criteria used in the past as well as the suggested pathophysiology of this condition.

Conclusion: Stress cardiomyopathy is an underdiagnosed reversible cardiomyopathy triggered by severe emotional or physical stress. It represents a spectrum of conditions with reversible severe left ventricular systolic dysfunction that includes neurogenic cardiomyopathy. It is not confined to the Japanese population and can affect people of any ethnic background or nationality.

背景:由于文献中关于应激性心肌病的报道越来越多,人们对这种疾病的认识也越来越高。虽然不同的名称被用来描述这种情况,但在临床、心电图、超声心动图和血管造影特征上的相似性表明,它们代表了不同潜在原因的同一谱系疾病。应激性心肌病的病理生理学仍有争议。方法:我们报告了在6个月的时间里收治的4例应激性心肌病患者,他们的表现不同,但临床过程、心电图、超声心动图和导管检查结果相似。年龄从22岁到81岁不等;四只都是雌性。在没有明显冠状动脉疾病的情况下,所有患者均表现出特征性的壁运动异常,经保守治疗后左心室功能自行恢复。结果:虽然4例患者临床表现不同,但均表现出应激性心肌病的特征,提示影响心肌的病理生理是相同的。我们对文献进行了回顾,讨论了这种疾病的历史、典型的临床特征、过去使用的诊断标准以及这种疾病的病理生理学。结论:应激性心肌病是一种由严重的情绪或身体压力引起的未被诊断的可逆性心肌病。它代表了一系列可逆的严重左心室收缩功能障碍,包括神经源性心肌病。它并不局限于日本人口,可以影响任何种族背景或国籍的人。
{"title":"Stress cardiomyopathy (takotsubo cardiomyopathy).","authors":"Samer Khouri,&nbsp;Naser Imran","doi":"10.4137/cmc.s3324","DOIUrl":"https://doi.org/10.4137/cmc.s3324","url":null,"abstract":"<p><strong>Background: </strong>Due to the rise in the number of reports of stress cardiomyopathy in the literature, awareness of this condition is increasing. Although different names have been used to describe this condition, the similarities in clinical, electrocardiographic, echocardiographic, and angiographic features suggest that they represent the same spectrum of diseases with different underlying causes. The pathophysiology of stress cardiomyopathy remains controversial.</p><p><strong>Methods: </strong>We describe a series of four cases of stress cardiomyopathy admitted to our institution over a period of six months with different presentations, but similar clinical course, EKG, echocardiographic, and catheterization findings. The ages ranged from 22 to 81 years; all four females. All showed characteristic wall motion abnormalities by imaging in the absence of significant coronary artery disease, with spontaneous recovery of left ventricular function with conservative therapy.</p><p><strong>Results: </strong>Although the patients presented with different clinical scenarios, all four showed characteristic features of stress cardiomyopathy suggesting that the pathophysiology affecting the myocardium was the same. We present a review of the literature with a discussion of the history of this condition, characteristic clinical features, and diagnostic criteria used in the past as well as the suggested pathophysiology of this condition.</p><p><strong>Conclusion: </strong>Stress cardiomyopathy is an underdiagnosed reversible cardiomyopathy triggered by severe emotional or physical stress. It represents a spectrum of conditions with reversible severe left ventricular systolic dysfunction that includes neurogenic cardiomyopathy. It is not confined to the Japanese population and can affect people of any ethnic background or nationality.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"93-9"},"PeriodicalIF":0.0,"publicationDate":"2009-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s3324","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Antiplatelet Resistance-Does it Exist and How to Measure it? 抗血小板抵抗——是否存在及如何测量?
Pub Date : 2009-09-03
S Saraf, I Bensalha, D A Gorog

Aspirin and clopidogrel are the most commonly used antiplatelet agents in patients with coronary artery disease. The existence of resistance to these agents has been a controversial issue and new drugs are being developed to overcome this problem. Laboratory tests, which can identify resistance and correlate this with clinical outcome, are being studied in order to identify patients at risk of future thrombotic events. We discuss the evidence for the existence of antiplatelet resistance-both in the laboratory and in the clinical setting. So far, platelet aggregometry has been considered the gold standard test, but is very operator dependant, time consuming, and has shown little correlation with other available tests of antiplatelet resistance. We discuss the available tests of platelet function, their limitations, and evidence for their use. A simple, rapid, near-patient test, which is affordable and useful in the clinical (not just laboratory) setting, could allow risk stratification of patients and individualization of antiplatelet medication to improve outcome.

阿司匹林和氯吡格雷是冠状动脉疾病患者最常用的抗血小板药物。对这些药物的耐药性一直是一个有争议的问题,正在开发新的药物来克服这个问题。目前正在研究能够确定耐药性并将其与临床结果相关联的实验室检测,以确定未来有血栓事件风险的患者。我们讨论抗血小板抵抗存在的证据-在实验室和在临床设置。到目前为止,血小板聚集被认为是金标准测试,但它非常依赖于操作人员,耗时,并且与其他可用的抗血小板耐药测试的相关性很小。我们讨论了现有的血小板功能测试,它们的局限性,以及它们使用的证据。一种简单、快速、接近患者的测试,在临床(不仅仅是实验室)环境中是负担得起的和有用的,可以允许患者的风险分层和抗血小板药物的个体化来改善结果。
{"title":"Antiplatelet Resistance-Does it Exist and How to Measure it?","authors":"S Saraf,&nbsp;I Bensalha,&nbsp;D A Gorog","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Aspirin and clopidogrel are the most commonly used antiplatelet agents in patients with coronary artery disease. The existence of resistance to these agents has been a controversial issue and new drugs are being developed to overcome this problem. Laboratory tests, which can identify resistance and correlate this with clinical outcome, are being studied in order to identify patients at risk of future thrombotic events. We discuss the evidence for the existence of antiplatelet resistance-both in the laboratory and in the clinical setting. So far, platelet aggregometry has been considered the gold standard test, but is very operator dependant, time consuming, and has shown little correlation with other available tests of antiplatelet resistance. We discuss the available tests of platelet function, their limitations, and evidence for their use. A simple, rapid, near-patient test, which is affordable and useful in the clinical (not just laboratory) setting, could allow risk stratification of patients and individualization of antiplatelet medication to improve outcome.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"77-91"},"PeriodicalIF":0.0,"publicationDate":"2009-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872576/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Myocardial Scar; Comparison Between F-FDG PET, CMR and Tc-Sestamibi. 心肌瘢痕的评价;F-FDG PET、CMR和Tc-Sestamibi的比较。
Pub Date : 2009-06-08 DOI: 10.4137/cmc.s730
Andrew Crean, Sadia N Khan, L Ceri Davies, Richard Coulden, David P Dutka

Objective: Patients with heart failure and ischaemic heart disease may obtain benefit from revascularisation if viable dysfunctional myocardium is present. Such patients have an increased operative risk, so it is important to ensure that viability is correctly identified. In this study, we have compared the utility of 3 imaging modalities to detect myocardial scar.

Design: Prospective, descriptive study.

Setting: Tertiary cardiac centre.

Patients: 35 patients (29 male, average age 70 years) with coronary artery disease and symptoms of heart failure (>NYHA class II).

Intervention: Assessment of myocardial scar by (99)Tc-Sestamibi (MIBI), (18)F-flurodeoxyglucose (FDG) and cardiac magnetic resonance (CMR).

Outcome measure: The presence or absence of scar using a 20-segment model.

Results: More segments were identified as nonviable scar using MIBI than with FDG or CMR. FDG identified the least number of scar segments per patient (7.4 +/- 4.8 with MIBI vs. 4.9 +/- 4.2 with FDG vs. 5.8 +/- 5.0 with CMR, p = 0.0001 by ANOVA). The strongest agreement between modalities was in the anterior wall with the weakest agreement in the inferior wall. Overall, the agreement between modalities was moderate to good.

Conclusion: There is considerable variation amongst these 3 techniques in identifying scarred myocardium in patients with coronary disease and heart failure. MIBI and CMR identify more scar than FDG. We recommend that MIBI is not used as the sole imaging modality in patients undergoing assessment of myocardial viability.

目的:心力衰竭和缺血性心脏病患者如果存在可存活的功能障碍心肌,可以从血运重建术中获益。这类患者手术风险增加,因此确保正确识别生存能力是很重要的。在这项研究中,我们比较了3种成像方式检测心肌疤痕的效用。设计:前瞻性描述性研究。地点:三级心脏中心。患者:35例(男性29例,平均年龄70岁)冠心病伴心衰症状(>NYHA II级)。干预措施:采用(99)Tc-Sestamibi (MIBI)、(18)f -氟氧葡萄糖(FDG)和心脏磁共振(CMR)评估心肌瘢痕。结果测量:采用20节段模型观察有无瘢痕。结果:与FDG或CMR相比,使用MIBI识别出更多的节段为不可活疤痕。FDG识别出每位患者最少的疤痕节段数(MIBI组为7.4 +/- 4.8,FDG组为4.9 +/- 4.2,CMR组为5.8 +/- 5.0,方差分析p = 0.0001)。两种模式之间最一致的是前壁,最不一致的是下壁。总的来说,两种治疗方式之间的一致性是中等到良好的。结论:在冠心病和心力衰竭患者的瘢痕心肌鉴别中,这3种方法有相当大的差异。MIBI和CMR比FDG更能识别出疤痕。我们建议在进行心肌活力评估的患者中,不要将MIBI作为唯一的成像方式。
{"title":"Assessment of Myocardial Scar; Comparison Between F-FDG PET, CMR and Tc-Sestamibi.","authors":"Andrew Crean,&nbsp;Sadia N Khan,&nbsp;L Ceri Davies,&nbsp;Richard Coulden,&nbsp;David P Dutka","doi":"10.4137/cmc.s730","DOIUrl":"https://doi.org/10.4137/cmc.s730","url":null,"abstract":"<p><strong>Objective: </strong>Patients with heart failure and ischaemic heart disease may obtain benefit from revascularisation if viable dysfunctional myocardium is present. Such patients have an increased operative risk, so it is important to ensure that viability is correctly identified. In this study, we have compared the utility of 3 imaging modalities to detect myocardial scar.</p><p><strong>Design: </strong>Prospective, descriptive study.</p><p><strong>Setting: </strong>Tertiary cardiac centre.</p><p><strong>Patients: </strong>35 patients (29 male, average age 70 years) with coronary artery disease and symptoms of heart failure (>NYHA class II).</p><p><strong>Intervention: </strong>Assessment of myocardial scar by (99)Tc-Sestamibi (MIBI), (18)F-flurodeoxyglucose (FDG) and cardiac magnetic resonance (CMR).</p><p><strong>Outcome measure: </strong>The presence or absence of scar using a 20-segment model.</p><p><strong>Results: </strong>More segments were identified as nonviable scar using MIBI than with FDG or CMR. FDG identified the least number of scar segments per patient (7.4 +/- 4.8 with MIBI vs. 4.9 +/- 4.2 with FDG vs. 5.8 +/- 5.0 with CMR, p = 0.0001 by ANOVA). The strongest agreement between modalities was in the anterior wall with the weakest agreement in the inferior wall. Overall, the agreement between modalities was moderate to good.</p><p><strong>Conclusion: </strong>There is considerable variation amongst these 3 techniques in identifying scarred myocardium in patients with coronary disease and heart failure. MIBI and CMR identify more scar than FDG. We recommend that MIBI is not used as the sole imaging modality in patients undergoing assessment of myocardial viability.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"69-76"},"PeriodicalIF":0.0,"publicationDate":"2009-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s730","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk. 循环CD34+细胞计数与无症状阿米什男性亚临床动脉粥样硬化程度相关,独立于10年Framingham风险
Pub Date : 2009-05-27 DOI: 10.4137/cmc.s2111
Lawrence F Bielak, Richard B Horenstein, Kathleen A Ryan, Patrick F Sheedy, John A Rumberger, Keith Tanner, Wendy Post, Braxton D Mitchell, Alan R Shuldiner, Patricia A Peyser

Background: Bone-marrow derived progenitor cells (PCs) may play a role in maintaining vascular health by actively repairing damaged endothelium. The purpose of this study in asymptomatic Old Order Amish men (n = 90) without hypertension or diabetes was to determine if PC count, as determined by CD34+ cell count in peripheral blood, was associated with 10-year risk of cardiovascular disease (CVD) and measures of subclinical atherosclerosis.

Methods and results: CD34+ cell count by fluorescence-activated cell sorting, coronary artery calcification (CAC) by electron beam computed tomography, and CVD risk factors were obtained. Carotid intimal-medial thickness (CIMT) also was obtained in a subset of 57 men. After adjusting for 10-year CVD risk, CD34+ cell count was significantly associated with CAC quantity (p = 0.03) and CIMT (p < 0.0001). A 1-unit increase in natural-log transformed CD34+ cell count was associated with an estimated 55.2% decrease (95% CI: -77.8% to -9.3%) in CAC quantity and an estimated 14.3% decrease (95% CI: -20.1% to -8.1%) in CIMT.

Conclusions: Increased CD34+ cell count was associated with a decrease in extent of subclinical atherosclerosis in multiple arterial beds, independent of 10-year CVD risk. Further investigations of associations of CD34+ cell count with subclinical atherosclerosis in asymptomatic individuals could provide mechanistic insights into the atherosclerotic process.

背景:骨髓源性祖细胞(PCs)可能通过主动修复受损内皮在维持血管健康中发挥作用。本研究在无高血压或糖尿病的无症状Old Order Amish男性(n = 90)中进行,目的是确定PC计数(由外周血CD34+细胞计数测定)是否与10年心血管疾病(CVD)风险和亚临床动脉粥样硬化指标相关。方法和结果:采用荧光活化细胞分选法获得CD34+细胞计数,采用电子束计算机断层扫描获得冠状动脉钙化(CAC)情况,并分析心血管疾病的危险因素。在57名男性中也获得了颈动脉内膜-内侧厚度(CIMT)。在调整10年心血管疾病风险后,CD34+细胞计数与CAC数量(p = 0.03)和CIMT (p < 0.0001)显著相关。自然对数转化CD34+细胞计数每增加1个单位,CAC数量减少55.2% (95% CI: -77.8%至-9.3%),CIMT减少14.3% (95% CI: -20.1%至-8.1%)。结论:CD34+细胞计数的增加与多动脉床亚临床动脉粥样硬化程度的降低有关,与10年CVD风险无关。进一步研究无症状个体中CD34+细胞计数与亚临床动脉粥样硬化的关系,可以为动脉粥样硬化过程提供机制见解。
{"title":"Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk.","authors":"Lawrence F Bielak,&nbsp;Richard B Horenstein,&nbsp;Kathleen A Ryan,&nbsp;Patrick F Sheedy,&nbsp;John A Rumberger,&nbsp;Keith Tanner,&nbsp;Wendy Post,&nbsp;Braxton D Mitchell,&nbsp;Alan R Shuldiner,&nbsp;Patricia A Peyser","doi":"10.4137/cmc.s2111","DOIUrl":"https://doi.org/10.4137/cmc.s2111","url":null,"abstract":"<p><strong>Background: </strong>Bone-marrow derived progenitor cells (PCs) may play a role in maintaining vascular health by actively repairing damaged endothelium. The purpose of this study in asymptomatic Old Order Amish men (n = 90) without hypertension or diabetes was to determine if PC count, as determined by CD34+ cell count in peripheral blood, was associated with 10-year risk of cardiovascular disease (CVD) and measures of subclinical atherosclerosis.</p><p><strong>Methods and results: </strong>CD34+ cell count by fluorescence-activated cell sorting, coronary artery calcification (CAC) by electron beam computed tomography, and CVD risk factors were obtained. Carotid intimal-medial thickness (CIMT) also was obtained in a subset of 57 men. After adjusting for 10-year CVD risk, CD34+ cell count was significantly associated with CAC quantity (p = 0.03) and CIMT (p < 0.0001). A 1-unit increase in natural-log transformed CD34+ cell count was associated with an estimated 55.2% decrease (95% CI: -77.8% to -9.3%) in CAC quantity and an estimated 14.3% decrease (95% CI: -20.1% to -8.1%) in CIMT.</p><p><strong>Conclusions: </strong>Increased CD34+ cell count was associated with a decrease in extent of subclinical atherosclerosis in multiple arterial beds, independent of 10-year CVD risk. Further investigations of associations of CD34+ cell count with subclinical atherosclerosis in asymptomatic individuals could provide mechanistic insights into the atherosclerotic process.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"53-60"},"PeriodicalIF":0.0,"publicationDate":"2009-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2856343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"28935312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Improvement of Young and Elderly Patient's Knowledge of Heart Failure After an Educational Session. 教育后青年和老年患者对心力衰竭知识的提高。
Pub Date : 2009-04-20 DOI: 10.4137/cmc.s2357
Jérôme Roncalli, Laurence Perez, Atul Pathak, Laure Spinazze, Sandrine Mazon, Olivier Lairez, Daniel Curnier, Joëlle Fourcade, Meyer Elbaz, Didier Carrié, Jacques Puel, Jean-Marie Fauvel, Michel Galinier

Background: Interest in the role of patient education sessions for optimizing the management of heart failure (HF) is increasing. We determined whether improvements in young and elderly patients' knowledge of HF and self-care behavior could be analyzed by administering a knowledge test before and after an educational session.

Methods: Stable heart failure patients (n = 115) were enrolled in a prospective cohort study from our Heart Failure educational centre in a university hospital. Patient knowledge of six major HF-related topics was assessed via a questionnaire distributed once before an educational session and twice afterward. Each answer was assigned a numerical value and the final score for each topic could range from 0 to 20. Scores >/= 15/20 were considered representative of a good level of knowledge.

Results: The level of knowledge was low (9.7/20) before the educational session but was significantly higher (16.3/20) during the 1st quarter after the session, and this benefit was maintained for up to 12 months (16.6/20). Knowledge levels increased in both younger and elderly patients, and the number of patients who had a good level of knowledge also increased after the educational session.

Conclusion: This study confirms that an HF knowledge test is feasible and that educational sessions improve the knowledge and self-management of both younger and elderly patients.

背景:对患者教育会议在优化心力衰竭(HF)管理中的作用的兴趣正在增加。我们确定是否可以通过在教育课程前后进行知识测试来分析年轻和老年患者对心衰知识和自我护理行为的改善。方法:稳定期心力衰竭患者(n = 115)入组一项前瞻性队列研究,该研究来自我们位于某大学医院的心力衰竭教育中心。患者对六个主要的hf相关主题的知识通过一份调查问卷进行评估,调查问卷在教育课程之前分发一次,之后分发两次。每个答案都有一个数值,每个主题的最终得分范围从0到20。得分>/= 15/20被认为代表良好的知识水平。结果:教育课程前知识水平较低(9.7/20),但在课程后第一季度知识水平显著提高(16.3/20),并且这种优势维持了长达12个月(16.6/20)。年轻患者和老年患者的知识水平都有所提高,在教育课程结束后,具有良好知识水平的患者数量也有所增加。结论:本研究证实心衰知识测试是可行的,教育课程提高了年轻和老年患者的心衰知识和自我管理。
{"title":"Improvement of Young and Elderly Patient's Knowledge of Heart Failure After an Educational Session.","authors":"Jérôme Roncalli,&nbsp;Laurence Perez,&nbsp;Atul Pathak,&nbsp;Laure Spinazze,&nbsp;Sandrine Mazon,&nbsp;Olivier Lairez,&nbsp;Daniel Curnier,&nbsp;Joëlle Fourcade,&nbsp;Meyer Elbaz,&nbsp;Didier Carrié,&nbsp;Jacques Puel,&nbsp;Jean-Marie Fauvel,&nbsp;Michel Galinier","doi":"10.4137/cmc.s2357","DOIUrl":"https://doi.org/10.4137/cmc.s2357","url":null,"abstract":"<p><strong>Background: </strong>Interest in the role of patient education sessions for optimizing the management of heart failure (HF) is increasing. We determined whether improvements in young and elderly patients' knowledge of HF and self-care behavior could be analyzed by administering a knowledge test before and after an educational session.</p><p><strong>Methods: </strong>Stable heart failure patients (n = 115) were enrolled in a prospective cohort study from our Heart Failure educational centre in a university hospital. Patient knowledge of six major HF-related topics was assessed via a questionnaire distributed once before an educational session and twice afterward. Each answer was assigned a numerical value and the final score for each topic could range from 0 to 20. Scores >/= 15/20 were considered representative of a good level of knowledge.</p><p><strong>Results: </strong>The level of knowledge was low (9.7/20) before the educational session but was significantly higher (16.3/20) during the 1st quarter after the session, and this benefit was maintained for up to 12 months (16.6/20). Knowledge levels increased in both younger and elderly patients, and the number of patients who had a good level of knowledge also increased after the educational session.</p><p><strong>Conclusion: </strong>This study confirms that an HF knowledge test is feasible and that educational sessions improve the knowledge and self-management of both younger and elderly patients.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"45-52"},"PeriodicalIF":0.0,"publicationDate":"2009-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s2357","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Platypnea-Orthodeoxia Syndrome in Two Previously Healthy Adults: A Case-based Review. 两名健康成人的肺动脉-正氧综合征:一项基于病例的回顾。
Pub Date : 2009-04-09 DOI: 10.4137/cmc.s2326
Leon M Ptaszek, Fidencio Saldana, Igor F Palacios, Sean M Wu

We describe here the clinical manifestations of platypnea-orthodeoxia in two patients with interatrial shunting. In both cases, the patients were asymptomatic prior to developing additional cardiopulmonary issues that apparently enhanced right-to-left intracardiac shunting. The patients were both treated with percutaneously deployed occlusion devices, with excellent results. Symptoms and positional oxygen desaturation resolved after device placement in both cases. In addition, these patients remain symptom-free 30 months after device implantation.

我们在此描述两例心房分流患者的肺动脉直通气的临床表现。在这两个病例中,患者在出现明显增强右至左心内分流的其他心肺问题之前均无症状。两例患者均采用经皮部署的闭塞装置治疗,效果良好。两例患者的症状和体位氧饱和度在放置器械后均得到缓解。此外,这些患者在植入装置30个月后仍无症状。
{"title":"Platypnea-Orthodeoxia Syndrome in Two Previously Healthy Adults: A Case-based Review.","authors":"Leon M Ptaszek,&nbsp;Fidencio Saldana,&nbsp;Igor F Palacios,&nbsp;Sean M Wu","doi":"10.4137/cmc.s2326","DOIUrl":"https://doi.org/10.4137/cmc.s2326","url":null,"abstract":"<p><p>We describe here the clinical manifestations of platypnea-orthodeoxia in two patients with interatrial shunting. In both cases, the patients were asymptomatic prior to developing additional cardiopulmonary issues that apparently enhanced right-to-left intracardiac shunting. The patients were both treated with percutaneously deployed occlusion devices, with excellent results. Symptoms and positional oxygen desaturation resolved after device placement in both cases. In addition, these patients remain symptom-free 30 months after device implantation.</p>","PeriodicalId":88450,"journal":{"name":"Clinical medicine. Cardiology","volume":"3 ","pages":"37-43"},"PeriodicalIF":0.0,"publicationDate":"2009-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4137/cmc.s2326","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29019922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
期刊
Clinical medicine. Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1